Turoctocog alfa is safe for the treatment of Indian patients with hemophilia A: Guardian 10 trial results.

John, M Joseph; Chakrabarti, Prantar; Apte, Shashikant; Bhattacharyya, Maitreyee; S, Chandrakala; Hansen, Trine; Kolla, Rohan; Ross, Cecil; Seth, Tulika; Siddharthan, Neeraj; Abraham, Aby

John, M Joseph; Chakrabarti, Prantar; Apte, Shashikant; Bhattacharyya, Maitreyee; S, Chandrakala; Hansen, Trine; Kolla, Rohan; Ross, Cecil; Seth, Tulika; Siddharthan, Neeraj; Abraham, Aby.

Afiliación

John MJ; Department of Clinical Haematology, Haemato-Oncology, & Bone Marrow (Stem Cell) Transplant Unit Christian Medical College and Hospital Ludhiana India.
Chakrabarti P; Department of Hematology NRS Medical College Kolkata India.
Apte S; Department of Hematology and Bone Marrow Transplantation Sahyadri Specialty Hospital Pune India.
Bhattacharyya M; Department of Hematology Calcutta Medical College Kolkata India.
S C; Department of Haematology KEM Hospital Mumbai India.
Hansen T; Novo Nordisk A/S Søborg Denmark.
Kolla R; Novo Nordisk India Bangalore India.
Ross C; St Johns Medical College Hospital Bangalore India.
Seth T; Department of Haematology All India Institute of Medical Sciences New Delhi India.
Siddharthan N; Department of Clinical Haematology Amrita Institute of Medical Sciences Kochi India.
Abraham A; Department of Hematology Christian Medical College Vellore India.

Res Pract Thromb Haemost ; 4(8): 1324-1330, 2020 Nov.

Article en En | MEDLINE | ID: mdl-33313471

Palabras clave

coagulation factor VIII; hemophilia; hemostatic; treatment; turoctocog alfa

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Res Pract Thromb Haemost Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google